These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37062138)

  • 1. Findings of the neuromuscular blocking agent rocuronium in blood from deceased subjects several months after exposure: A report of two cases.
    Frost J; Gundersen POM; Brede WR; Gjerde S; Pleym H; Slørdal L
    Forensic Sci Int; 2023 Jun; 347():111680. PubMed ID: 37062138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rocuronium: high risk for anaphylaxis?
    Rose M; Fisher M
    Br J Anaesth; 2001 May; 86(5):678-82. PubMed ID: 11575345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed-onset malignant hyperthermia in association with rocuronium use.
    Beggs AE; McCann JQ; Powers JM
    Am J Health Syst Pharm; 2012 Jul; 69(13):1128-34. PubMed ID: 22722591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prick testing for neuromuscular blocking drugs.
    Dhonneur G
    Anesth Analg; 2004 Dec; 99(6):1880-1881. PubMed ID: 15562106
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
    Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
    J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactic shock to neuromuscular blocking agent: a familial history.
    Duvaldestin P; Wigdorowicz C; Gabriel I
    Anesthesiology; 1999 Apr; 90(4):1211-2. PubMed ID: 10201697
    [No Abstract]   [Full Text] [Related]  

  • 7. Rocuronium anaphylaxis in a 3-year-old girl with no previous exposure to neuromuscular blocking agents.
    Choi SH; Yi JW; Rha YH
    Asian Pac J Allergy Immunol; 2013 Jun; 31(2):163-6. PubMed ID: 23859417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocuronium anaphylaxis and multiple neuromuscular blocking drug sensitivities.
    Matthey P; Wang P; Finegan BA; Donnelly M
    Can J Anaesth; 2000 Sep; 47(9):890-3. PubMed ID: 10989860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report.
    Hung SK; Yeh CC; Ting PC; Chen CH; Kao MC
    J Int Med Res; 2022 Jul; 50(7):3000605221113913. PubMed ID: 35869623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rocuronium-Induced Dilated Nonreactive Pupils in a Patient With Coronavirus Disease 2019: A Case Report.
    Rodrigues EDP; da Costa GC; Braga DQ; Pinto JEDSS; Lessa MA
    A A Pract; 2021 Jun; 15(7):e01491. PubMed ID: 34166250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Neuromuscular Blockade Monitoring: Two Pictures of Unexpected Rocuronium Effect: A Case Report.
    Leonard PA; Todd MM
    A A Case Rep; 2017 Oct; 9(7):190-192. PubMed ID: 28542054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex in the management of rocuronium-induced anaphylaxis.
    McDonnell NJ; Pavy TJ; Green LK; Platt PR
    Br J Anaesth; 2011 Feb; 106(2):199-201. PubMed ID: 21149287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular Effects of Rocuronium Bromide in Patients in Statin Therapy for at least Three Months.
    Ren H; Lv H
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):582-587. PubMed ID: 27234897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged residual paralysis after a single intubating dose of rocuronium.
    Claudius C; Karacan H; Viby-Mogensen J
    Br J Anaesth; 2007 Oct; 99(4):514-7. PubMed ID: 17675361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex and rocuronium-induced anaphylaxis.
    Takazawa T; Mitsuhata H; Mertes PM
    J Anesth; 2016 Apr; 30(2):290-7. PubMed ID: 26646837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged neuromuscular blockade associated with rocuronium.
    Lewis KS; Santucci VN; Normoyle DL; Rothenberg DM
    Am J Health Syst Pharm; 1999 Jun; 56(11):1114-8. PubMed ID: 10385459
    [No Abstract]   [Full Text] [Related]  

  • 17. Early skin and challenge testing after rocuronium anaphylaxis.
    Schulberg EM; Webb AR; Kolawole H
    Anaesth Intensive Care; 2016 May; 44(3):425-7. PubMed ID: 27246945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allergy investigations after two cases of adverse reactions to a neuromuscular blocking agent and management for subsequent general anaesthesia].
    Louvier N; Chomel A; Collet E; Juniot A; Pillet M
    Ann Fr Anesth Reanim; 2003 Jan; 22(1):54-7. PubMed ID: 12738022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex approved to reverse NMBA effects.
    Thompson CA
    Am J Health Syst Pharm; 2016 Feb; 73(3):100. PubMed ID: 26796899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.